Positive donor cytomegalovirus IgG status as a major risk factor for liver allograft recipient infection

Transplantation Proceedings

Volumn 29, Issue 7, 1997, Pages 2859-2860

  Neumann, U P ^a   Knoop, M ^a   Langrehr, J M ^a   Jonas, S ^a   Bechstein, W O ^a   Lang, M ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOSPORIN A; GANCICLOVIR; INOLIMOMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

CONFERENCE PAPER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HUMAN; INFECTION RISK; LEGIONNAIRE DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; ORGAN DONOR; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS HEPATITIS;

ACUTE DISEASE; ANTIBODIES, VIRAL; CHRONIC DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; LIVER TRANSPLANTATION; MORBIDITY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS;

EID: 0030731235     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(97)00708-2     Document Type: Conference Paper

References (9)

1. Fiala M, Payne JE, Berne TV, et al: J Infect Dis 132:421, 1975
2. Sayage LH, Gonwa TA, Goldstein RM, et al: Transplant Int 2:96, 1989
3. Rubin RH, Young LS: Clinical approach to infections in the immune compromised patient, 2nd ed. New York: Plenum; 1988, p 557
4. Martin M, Manez R, Linden P, et al: Transplantation 58:779, 1994
5. Manez R, White S, Kusne S, et al: Transplant Proc 25:908, 1993
6. Schrier RD, Rice GPA, Oldstone MBA: J Infect Dis: 153: 1084, 1986
7. Roenhorst HW, Middeldorp JM, Beelen et al: Clin Exp Immunol 59:709, 1985
8. Waltzer WC, Arnold AN, Anaise D, et al: Transplant Proc 19:4077, 1987
9. O'Grady JG, Sutherland S, Harvey F, et al: Lancet August: 302, 1988